The science of genome engineering—the ability to add, remove, or alter precise locations in the genome—is of great interest to a wide variety of researchers, ranging from synthetic biologists innovating solutions for feed, fuel, and new materials to biomedical scientists hoping to find new ways to prevent or treat hereditary maladies such as cystic fibrosis, hemophilia, and sickle cell disease. Inscripta is a newly founded company providing genome tools to empower groundbreaking innovations. Learn how Agilent’s genomics, automation, analytics, and data management platforms are allowing them to maximize their resources and offer their shared customers an integrated genome engineering ecosystem.